Franklin Genomic Advancements ETF Rating $30.39 +3.24 (+11.92%) Closing price 02:48 PM EasternExtended Trading$30.40 +0.00 (+0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock Franklin Genomic Advancements ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HELX Aggregate RatingModerate Buy 2.77Holdings in HELX have an aggregate rating of Moderate Buy based on 366 analyst ratings issued in the past year covering 22 companies (65.5% of the portfolio).HELX Aggregate Price Target$30.39High Prediction$30.39Average Prediction$30.39Low Prediction$30.39Holdings in HELX have an aggregate price target of $30.39 and a range of $30.39 to $30.39 covering 22 companies (65.5% of the portfolio).HELX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Franklin Genomic Advancements ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 HELX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.08%NTRANatera$168.51-3.0%3.6493 of 5 stars3.06$194.00 15.1%18Positive News4.88%ALNYAlnylam Pharmaceuticals$465.89-0.6%3.784 of 5 stars2.85$421.28 -9.6%27Positive NewsAnalyst ForecastInsider Trade4.65%GHGuardant Health$54.90-3.3%4.0898 of 5 stars3.06$58.24 6.1%18News CoveragePositive NewsInsider TradeGap Down4.42%MEDPMedpace$490.64-1.4%4.2183 of 5 stars1.94$422.27 -13.9%16News CoverageAnalyst Forecast4.03%INSMInsmed$145.93+0.1%3.3273 of 5 stars2.94$139.86 -4.2%17Positive News3.43%KRYSKrystal Biotech$143.68-0.5%4.9303 of 5 stars2.86$209.00 45.5%7Positive News3.42%VRTXVertex Pharmaceuticals$394.53-0.7%4.9046 of 5 stars2.57$496.05 25.7%28News CoveragePositive NewsAnalyst Forecast3.04%CTVACorteva$75.07+2.8%4.5692 of 5 stars2.86$80.25 6.9%14News CoveragePositive News2.99%AZNAstraZeneca$79.56-1.9%2.8007 of 5 stars2.75$86.00 8.1%4Trending NewsShort Interest ↑Analyst Revision2.73%LLYEli Lilly and Company$754.90-0.2%4.9979 of 5 stars2.70$950.17 25.9%23Trending News2.70%UTHRUnited Therapeutics$405.02+0.0%4.7856 of 5 stars2.69$438.85 8.4%13Trending NewsAnalyst ForecastInsider TradeAnalyst Revision2.67%BBIOBridgeBio Pharma$51.21-2.6%4.4508 of 5 stars3.00$63.94 24.9%17Positive NewsAnalyst Forecast2.48%BNTXBioNTech$96.74-7.3%2.5094 of 5 stars2.76$135.80 40.4%17Gap DownHigh Trading Volume2.40%CDNSCadence Design Systems$343.48-3.2%4.7396 of 5 stars2.73$364.33 6.1%15News CoveragePositive News2.22%TEMTempus AI$86.38-2.7%2.1882 of 5 stars2.54$70.17 -18.8%13Trending NewsAnalyst ForecastOptions Volume2.20%REGNRegeneron Pharmaceuticals$560.00-1.4%4.7604 of 5 stars2.82$817.67 46.0%28Positive NewsShort Interest ↑2.08%LGNDLigand Pharmaceuticals$165.75-0.8%4.2328 of 5 stars3.00$176.50 6.5%6Short Interest ↑2.06%ADPTAdaptive Biotechnologies$12.61-6.5%3.6735 of 5 stars2.88$12.38 -1.9%8Positive News1.95%TMOThermo Fisher Scientific$479.48-2.4%4.9735 of 5 stars2.77$592.24 23.5%22Trending NewsAnalyst UpgradeInsider TradeAnalyst Revision1.86%DHRDanaher$190.07-2.6%4.9923 of 5 stars2.85$246.35 29.6%20News CoveragePositive NewsDividend Announcement1.71%QGENQIAGEN$45.30-1.7%4.4681 of 5 stars2.27$49.69 9.7%11Positive News1.52%EXASExact Sciences$53.94-3.7%4.83 of 5 stars2.88$68.05 26.2%24Trending NewsAnalyst ForecastShort Interest ↓Analyst Revision This page (BATS:HELX) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredCollege grad makes $64,000 a monthIt's easy to feel like you've missed out on the biggest stock market boom of the century. But if you want t...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HELX Stock Alerts